JP2009532384A5 - - Google Patents

Download PDF

Info

Publication number
JP2009532384A5
JP2009532384A5 JP2009503312A JP2009503312A JP2009532384A5 JP 2009532384 A5 JP2009532384 A5 JP 2009532384A5 JP 2009503312 A JP2009503312 A JP 2009503312A JP 2009503312 A JP2009503312 A JP 2009503312A JP 2009532384 A5 JP2009532384 A5 JP 2009532384A5
Authority
JP
Japan
Prior art keywords
aaa
amino acid
ala
lys
amino acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009503312A
Other languages
English (en)
Japanese (ja)
Other versions
JP5355383B2 (ja
JP2009532384A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/065645 external-priority patent/WO2007115175A2/en
Publication of JP2009532384A publication Critical patent/JP2009532384A/ja
Publication of JP2009532384A5 publication Critical patent/JP2009532384A5/ja
Application granted granted Critical
Publication of JP5355383B2 publication Critical patent/JP5355383B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009503312A 2006-03-30 2007-03-30 環状ナトリウム利尿ペプチド構築物 Expired - Fee Related JP5355383B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US74396106P 2006-03-30 2006-03-30
US74396006P 2006-03-30 2006-03-30
US60/743,960 2006-03-30
US60/743,961 2006-03-30
PCT/US2007/065645 WO2007115175A2 (en) 2006-03-30 2007-03-30 Cyclic natriuretic peptide constructs

Publications (3)

Publication Number Publication Date
JP2009532384A JP2009532384A (ja) 2009-09-10
JP2009532384A5 true JP2009532384A5 (enExample) 2010-05-20
JP5355383B2 JP5355383B2 (ja) 2013-11-27

Family

ID=38564246

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009503312A Expired - Fee Related JP5355383B2 (ja) 2006-03-30 2007-03-30 環状ナトリウム利尿ペプチド構築物

Country Status (14)

Country Link
US (2) US7622440B2 (enExample)
EP (1) EP2001518B1 (enExample)
JP (1) JP5355383B2 (enExample)
KR (1) KR101434612B1 (enExample)
AU (1) AU2007233116B2 (enExample)
BR (1) BRPI0709427A2 (enExample)
CA (1) CA2647143A1 (enExample)
CO (1) CO6140040A2 (enExample)
DK (1) DK2001518T3 (enExample)
EA (1) EA016804B1 (enExample)
ES (1) ES2430323T3 (enExample)
IL (1) IL194262A (enExample)
MX (1) MX2008012663A (enExample)
WO (1) WO2007115175A2 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8580746B2 (en) * 2006-03-30 2013-11-12 Palatin Technologies, Inc. Amide linkage cyclic natriuretic peptide constructs
US7795221B2 (en) 2006-03-30 2010-09-14 Palatin Technologies, Inc. Linear natriuretic peptide constructs
BRPI0709405A2 (pt) * 2006-03-30 2011-07-12 Palatin Technologies Inc composto lineares ou cìclicos
KR101434612B1 (ko) * 2006-03-30 2014-08-26 팔라틴 테크놀로지스 인코포레이티드 사이클릭 나트륨 이뇨 펩타이드 구조물
US7964181B2 (en) 2006-03-30 2011-06-21 Palatin Technologies, Inc. Amino acid surrogates for peptidic constructs
US8114844B2 (en) 2006-03-30 2012-02-14 Palatin Technologies, Inc. Linear and cyclic melanocortin receptor-specific peptidomimetics
MX2011012875A (es) 2009-06-05 2012-02-28 13Therapeutics Inc Peptidos inmunoreguladores y metodos de uso.
US9458198B1 (en) 2009-06-26 2016-10-04 Shire Orphan Therapies Gmbh Cyclic peptide-based NPR-B agonists
MX354005B (es) * 2009-09-25 2018-02-08 Shire Orphan Therapies Gmbh Agonistas npr-b novedosos.
AR078446A1 (es) 2009-12-18 2011-11-09 Alcon Res Ltd Agonistas de npr-b. uso.
IE20100174A1 (en) * 2010-03-25 2012-02-29 Trinity College Dublin Transdermal administration of peptides
CA2796725A1 (en) * 2010-04-21 2011-10-27 Palatin Technologies, Inc. Uses of natriuretic peptide constructs
WO2012138879A2 (en) 2011-04-06 2012-10-11 13Therapeutics, Inc. Peptides for the treatment of hearing
KR101867026B1 (ko) 2011-12-28 2018-07-20 대우조선해양 주식회사 밸러스트 수 처리 시스템의 미처리 수 처리 모듈
BR112021024938A2 (pt) 2019-06-12 2022-01-25 Novartis Ag Anticorpos de receptor 1 de peptídeo natriurético e métodos de uso
US20220280647A1 (en) * 2019-08-12 2022-09-08 Biomarin Pharmaceutical Inc. Hydrophobic Peptide Salts for Extended Release Compositions

Family Cites Families (89)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4251438A (en) * 1979-06-14 1981-02-17 The Upjohn Company Piperazinone and piperazine polypeptides
US4341698A (en) * 1979-06-21 1982-07-27 Richardson-Merrell Inc. Enkaphalin derivatives
US4496544A (en) 1983-11-10 1985-01-29 Washington University Atrial Peptides
US4952561A (en) 1984-02-07 1990-08-28 Merck & Co., Inc. Cardiac atrial peptides
JPS60184098A (ja) 1984-03-02 1985-09-19 Suntory Ltd 新規なペプチド及びこれを有効成分とする利尿剤
US4618600A (en) 1984-04-19 1986-10-21 Biotechnology Research Associates, J.V. Novel polypeptide diuretic/vasodilators
US5212286A (en) 1984-04-19 1993-05-18 Scios Nova Inc. Atrial natriuretic/vasodilator peptide compounds
ATE120759T1 (de) 1984-04-19 1995-04-15 Scios Nova Inc Atrielle natriumuretische/gefässerweiterende polypeptide.
EP0177610A1 (en) 1984-04-24 1986-04-16 The Salk Institute For Biological Studies Atrial peptide analogs
JPH0672155B2 (ja) 1984-08-24 1994-09-14 塩野義製薬株式会社 α−ｈＡＮＰ抗血清作製用ポリペプチド
US4609725A (en) 1984-10-09 1986-09-02 Merck & Co., Inc. Cardiac atrial peptides
US4757048A (en) 1985-11-05 1988-07-12 Biotechnology Research Associates J.V. Synthetic analogs of atrial natriuretic peptides
EP0223143A3 (en) 1985-11-05 1989-04-12 California Biotechnology, Inc. Analogs of atrial natriuretic peptides
DE3614833A1 (de) 1986-01-16 1987-07-23 Hoechst Ag Peptide mit vasorelaxierender, natriuretischer und diuretischer wirkung, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung
US5057603A (en) 1986-01-31 1991-10-15 Merck & Co., Inc. Peptides having ANF activity
US4716147A (en) 1986-03-27 1987-12-29 Monsanto Company Synthetic airial peptides
EP0246795A3 (en) 1986-05-20 1990-04-04 Advanced Peptide Development Limited Synthetic natriuretic peptides
CA1339678C (en) 1986-09-29 1998-02-17 Takeda Chemical Industries Ltd. Atrial natriuretic peptide derivative, its production and use thereof for treating gardiac or cerebral circulatory disease
US4804650A (en) 1986-10-28 1989-02-14 Biotechnology Research Associates, J.V. Analogs of atrial natriuretic peptides
DK531986D0 (da) 1986-11-07 1986-11-07 Novo Industri As Peptider
DE3878231T2 (de) 1987-03-02 1993-05-27 Bissendorf Peptide Gmbh Neues cadiodilatin-fragment, prozess zu dessen herstellung und dessen anwendung.
US5376635A (en) 1987-03-15 1994-12-27 Bio-Mega/Boehringer Ingelheim Research Inc. Fluorine containing atrial natriuretic peptides
US5095004A (en) 1987-03-25 1992-03-10 Bio-Mega Inc. Fluorine containing atrial natriuretic peptides
US5091366A (en) 1987-05-19 1992-02-25 Merck & Co., Inc. Peptides having ANF activity
US4816443A (en) 1987-05-19 1989-03-28 Merck & Co., Inc. Piptides having ANF activity
IL86386A0 (en) 1987-05-21 1988-11-15 Merrell Dow Pharma Novel anf derivatives
JP2544929B2 (ja) 1987-06-17 1996-10-16 第一化学薬品 株式会社 新規生理活性ペプチド
US4935492A (en) 1987-12-24 1990-06-19 California Biotechnology Inc. Cyclic analogs of atrial natriuretic peptides
EP0323740A3 (en) 1987-12-24 1990-12-12 California Biotechnology, Inc. Linear analogs of atrial natriuretic peptides
US5047397A (en) 1988-08-26 1991-09-10 California Biotechnology Inc. Linear analogs of atrial natriuretic peptides
EP0341603A3 (en) 1988-05-09 1990-07-04 Abbott Laboratories Atrial peptide derivatives
CA1339210C (en) 1988-05-31 1997-08-05 John Lewicki Recombinant techniques for production of novel natriuretic and vasodilator peptides
US5114923A (en) 1988-05-31 1992-05-19 California Biotechnology Inc. Recombinant techniques for production of novel natriuretic and vasodilator peptides
US5057495A (en) 1988-06-24 1991-10-15 Queen's University At Kingston Atrial hypotensive peptide
DK380288D0 (da) 1988-07-07 1988-07-07 Novo Industri As Hidtil ukendet peptider
WO1990001940A1 (en) 1988-08-18 1990-03-08 California Biotechnology Inc. Atrial natriuretic peptide clearance inhibitors
US4938763B1 (en) 1988-10-03 1995-07-04 Atrix Lab Inc Biodegradable in-situ forming implants and method of producing the same
US5106834A (en) 1988-12-27 1992-04-21 G. D. Searle & Co. Linear free-sulfhydryl-containing oligopeptide derivatives as antihypertensive agents
DK0385476T4 (da) 1989-03-01 1999-12-20 Shionogi & Co Fysiologisk aktivt polypeptid og DNA
GR1001018B (el) 1989-05-24 1993-03-31 Abbott Lab Μεθοδος παρασκευης προδρομικων πεπτικων παραγωγων.
DK0479948T3 (da) 1989-06-23 1999-05-25 Genentech Inc Sammensætninger og fremgangsmåder til syntese af natriuretisk protein-receptor B og anvendelsesfremgangsmåder
JP3219096B2 (ja) 1990-05-10 2001-10-15 ニコメド ファーマ エイエス ｎ―グリコフロール類及びｎ―エチレングリコール類を含有する医薬製剤
US5204328A (en) 1990-06-26 1993-04-20 Merck & Co., Inc. Peptides having atrial natriuretic factor activity
US5202239A (en) 1990-08-07 1993-04-13 Scios Nova Inc. Expression of recombinant polypeptides with improved purification
SK32693A3 (en) 1990-10-11 1993-09-09 Boehringer Ingelheim Kg Cyclopeptides, a method of preparing them and their use as drugs
JP2809533B2 (ja) 1991-01-31 1998-10-08 壽之 松尾 Ｃｎｐ類似体ペプチド
US5190922A (en) 1991-06-04 1993-03-02 Abbott Laboratories Terminally modified tri-, tetra- and pentapeptide anaphylatoxin receptor ligands
JP2925391B2 (ja) 1992-01-09 1999-07-28 サントリー株式会社 Ａｒｄｓ治療用医薬組成物
US5977070A (en) 1992-07-14 1999-11-02 Piazza; Christin Teresa Pharmaceutical compositions for the nasal delivery of compounds useful for the treatment of osteoporosis
AU6360394A (en) 1993-03-03 1994-09-26 Mayo Foundation For Medical Education And Research Vasonatrin peptide and analogs thereof
US5681811A (en) 1993-05-10 1997-10-28 Protein Delivery, Inc. Conjugation-stabilized therapeutic agent compositions, delivery and diagnostic formulations comprising same, and method of making and using the same
US5359030A (en) 1993-05-10 1994-10-25 Protein Delivery, Inc. Conjugation-stabilized polypeptide compositions, therapeutic delivery and diagnostic formulations comprising same, and method of making and using the same
TW394760B (en) * 1993-09-07 2000-06-21 Hoffmann La Roche Novel Carboxamides, process for their preparation and pharmaceutical composition containing the same
US5846932A (en) 1993-11-12 1998-12-08 Genentech, Inc. Receptor specific atrial natriuretic peptides
ES2194895T3 (es) 1993-11-12 2003-12-01 Genentech Inc Peptidos natriureticas atriales especifico de un receptor.
US5665704A (en) 1993-11-12 1997-09-09 Genentech, Inc. Receptor specific atrial natriuretic peptides
US6525022B1 (en) 1993-11-12 2003-02-25 Genentech, Inc. Receptor specific atrial natriuretic peptides
US5567662A (en) 1994-02-15 1996-10-22 The Dow Chemical Company Method of making metallic carbide powders
FR2717484A1 (fr) 1994-03-16 1995-09-22 Pf Medicament Nouveaux composés pseudo-bis-peptidiques analogues de la CCK, leur procédé de préparation, leur utilisation à titre de médicament et les compositions pharmaceutiques les comprenant .
US6150402A (en) 1994-08-15 2000-11-21 Loma Linda University Medical Center Natriuretic compounds
US5932462A (en) 1995-01-10 1999-08-03 Shearwater Polymers, Inc. Multiarmed, monofunctional, polymer for coupling to molecules and surfaces
US5672662A (en) 1995-07-07 1997-09-30 Shearwater Polymers, Inc. Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications
DE69733560T2 (de) 1996-03-04 2006-05-11 Scios Inc., Fremont TESTVERFAHREN UND REAGENZIEN ZUR QUANTIFIZIERUNG VON hBNP
US6028055A (en) 1996-10-22 2000-02-22 Genetech, Inc. Receptor selective BNP
ES2256898T3 (es) 1996-12-20 2006-07-16 Alza Corporation Composicion de gel y procedimientos.
US5908825A (en) 1997-01-09 1999-06-01 University Of Maryland At Baltimore Dosage composition for nasal delivery and method of use of the same
US5965533A (en) 1997-05-23 1999-10-12 Baxter International Inc. Atrial natriuretic peptide (ANP) as an additive to peritoneal dialysis solutions
US6013630A (en) 1997-08-21 2000-01-11 Curagen Corporation Atrial natriuretic factor mutants and ischemic stroke
WO1999012576A2 (en) 1997-09-11 1999-03-18 Musc Foundation For Research Development Methods and compositions for treating cardiac and renal disorders with atrial natriuretic peptide and tissue kallikrein gene therapy
US6193991B1 (en) 1997-10-29 2001-02-27 Atul J. Shukla Biodegradable delivery systems of biologically active substances
AUPP254898A0 (en) * 1998-03-24 1998-04-23 University Of Queensland, The Peptide turn mimetics
CA2345414A1 (en) 1998-09-28 2000-04-06 Santen Pharmaceutical Co., Ltd. Eyedrops for promoting lacrimal secretion or treating keratoconjunctival disorders containing natriuretic peptide as active ingredient
US20040266673A1 (en) 2002-07-31 2004-12-30 Peter Bakis Long lasting natriuretic peptide derivatives
US6309633B1 (en) 1999-06-19 2001-10-30 Nobex Corporation Amphiphilic drug-oligomer conjugates with hydroyzable lipophile components and methods for making and using the same
AU7352200A (en) 1999-09-01 2001-03-26 Regents Of The University Of California, The Novel natriuretic peptide receptors, interacting compounds and methods of regulating proliferation and/or survival of neurons
US6407211B1 (en) 1999-12-17 2002-06-18 Mayo Foundation For Medical Education And Research Chimeric natriuretic peptides
MXPA02006216A (es) 1999-12-22 2004-02-26 Nektar Therapeutics Al Corp Derivados estericamente impedidos de polimeros solubles en agua.
US6911447B2 (en) * 2001-04-25 2005-06-28 The Procter & Gamble Company Melanocortin receptor ligands
US6858580B2 (en) 2001-06-04 2005-02-22 Nobex Corporation Mixtures of drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
WO2003081246A1 (en) 2002-03-18 2003-10-02 Scios Inc. Treatment of congestive heart failure with natriuretic peptide and a diuretic
US20050113286A1 (en) 2002-03-18 2005-05-26 Schreiner George F. Methods for treating congestive heart failure
US20040077537A1 (en) 2002-03-18 2004-04-22 Schreiner George F. Method for treating congestive heart failure
EP1569683B1 (en) 2002-11-26 2010-03-03 Biocon Limited Modified natriuretic compounds, conjugates, and uses thereof
CA2788505C (en) 2003-02-26 2018-09-04 Nektar Therapeutics Polymer-factor viii moiety conjugates
WO2005070446A1 (en) 2004-01-15 2005-08-04 Scios Inc. Method for treating cardiac remodeling following myocardial injury
EP1730181A2 (en) 2004-01-27 2006-12-13 Compugen USA, Inc. Novel brain natriuretic peptide variants and methods of use thereof
CN101232874A (zh) 2004-08-11 2008-07-30 阿尔扎公司 透皮递送利钠肽的装置和方法
KR101434612B1 (ko) * 2006-03-30 2014-08-26 팔라틴 테크놀로지스 인코포레이티드 사이클릭 나트륨 이뇨 펩타이드 구조물
US7795221B2 (en) 2006-03-30 2010-09-14 Palatin Technologies, Inc. Linear natriuretic peptide constructs

Similar Documents

Publication Publication Date Title
JP2009532384A5 (enExample)
JP2009532385A5 (enExample)
KR102812908B1 (ko) 인크레틴 유사체의 제조 방법
JP2012530145A5 (enExample)
JP2011511778A5 (enExample)
RU2008141280A (ru) Агонисты рецептора нейромедина u и их применение
JP2011502159A5 (enExample)
KR950702578A (ko) 파라티로이드 호르몬(pth) 및 파라티로이드 호르몬 관련 펩티드(pthrp)의 유사체, 이들의 합성 및 골다공증 치료를 위한 이들의 용도(analogs of pth and pthrp, their synthesis and use for the treatment of osteoporosis)
JP2011524418A5 (enExample)
KR20140100937A (ko) 펩티도미메틱 거대고리
ES2200178T3 (es) Analogos de hgh-rh(1-29)nh2 que tienen actividad antagonista.
JP2024520861A (ja) 遺伝性ヘモクロマトーシスの治療のためのヘプシジン模倣体
JPS63154699A (ja) バソプレシン拮抗剤
US7452865B2 (en) Antagonistic analogs of GH RH (2003)
CN101983068B (zh) N末端和c末端取代的人gh-rh拮抗类似物
CA2069943A1 (en) Synthetic calcitonin peptides
JP2837352B2 (ja) 胃腸運動活性を抑制するモチリン類似ポリペプチド
IL171204A (en) Compounds and pharmaceutical compositions containing them and use thereof for the preparation of medicaments
CZ91497A3 (en) Peptides and pharmaceutical preparations containing thereof
US20110195900A1 (en) Peptidic pth receptor agonists
KR100360975B1 (ko) 위장운동자극활성을가지는폴리펩티드
JPH04502629A (ja) 還元不可逆性ボンベシンアンタゴニスト
EA047599B1 (ru) Способы получения аналогов инкретина
JPH09221500A (ja) カルシトニン類似体
RU97112094A (ru) Ингибиторы фибронектиновой адгезии